Related references
Note: Only part of the references are listed.Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis
Wenjia Hui et al.
PLOS ONE (2019)
Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome
Gianluca Ianiro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition
Zev H. Davidovics et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)
Fecal microbiota transplantation in recurrent Clostridium difficile infection: A retrospective single-center chart review
Pamela Kim et al.
JGH OPEN (2019)
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions
G. Ianiro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis
Gianluca Ianiro et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H. Mullish et al.
GUT (2018)
Methodological quality and synthesis of case series and case reports
Mohammad Hassan Murad et al.
BMJ EVIDENCE-BASED MEDICINE (2018)
Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection
Yvette H. van Beurden et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
Fecal Microbiota Transplant From a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial
Jasmohan S. Bajaj et al.
HEPATOLOGY (2017)
Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection A Collaborative Analysis of Individual Patient Data From 14 Studies
Luis Furuya-Kanamori et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2017)
Fecal microbiota transplantation outcomes in immunocompetent and immunocompromised patients: A single-center experience
Sally Alrabaa et al.
TRANSPLANT INFECTIOUS DISEASE (2017)
Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
Anca Trifan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?
Guihua Tang et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
Fecal microbiota transplant in severe and severe-complicated &ITClostridium difficile&IT: A promising treatment approach
Monika Fischer et al.
GUT MICROBES (2017)
Proton pump inhibitors affect the gut microbiome
Floris Imhann et al.
GUT (2016)
Endoscopic peroral jejunal fecal microbiota transplantation
Alexander Link et al.
DIGESTIVE AND LIVER DISEASE (2016)
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection A Randomized Clinical Trial
Christine H. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Fecal microbiota transplantation via fluoroscopy-guided nasojejunal catheter placement: indications, technique, and the role of radiology
Julien S. Wonderlick et al.
ABDOMINAL RADIOLOGY (2016)
Systematic Review: Adverse Events of Fecal Microbiota Transplantation
Sinan Wang et al.
PLOS ONE (2016)
Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection
Bruce E. Hirsch et al.
BMC INFECTIOUS DISEASES (2015)
Initial experience with fecal microbiota transplantation in Clostridium difficile Infection Transplant protocol and preliminary results
Ana Ponte et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2015)
What are the effects of proton pump inhibitors on the small intestine?
Shunji Fujimori
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection
Emily G. McDonald et al.
JAMA INTERNAL MEDICINE (2015)
Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study
Ilan Youngster et al.
CLINICAL INFECTIOUS DISEASES (2014)
European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection
S. B. Debast et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Fecal microbiome transplantation for recurrent Clostridium difficile infection: Report on a case series
Timothy A. Rubin et al.
ANAEROBE (2013)
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications
Joel J. Heidelbaugh
THERAPEUTIC ADVANCES IN DRUG SAFETY (2013)
Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia
C. P. C. de Jager et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea
Kjetil Garborg et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2010)
Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube
J Aas et al.
CLINICAL INFECTIOUS DISEASES (2003)
Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity
K Zedtwitz-Liebenstein et al.
CRITICAL CARE MEDICINE (2002)
Share Paper
